Iopamidol and Conray 60: comparison in superselective angiography

Area of Science:

• Neuroradiology
• Medical Imaging
• Pharmacology

Background:

• Cerebral arteriography requires effective contrast agents.
• Patient comfort and reduced motion are crucial for diagnostic accuracy.
• Iopamidol and Conray 60 are iodinated contrast media used in vascular imaging.

Purpose of the Study:

• To compare the tolerability and efficacy of iopamidol versus Conray 60 in selective and superselective cerebral arteriography.
• To assess patient-reported pain and burning sensations.
• To evaluate the impact on patient motion during the procedure.

Main Methods:

• A comparative study involving twelve patients undergoing cerebral arteriography.
• Direct comparison of iopamidol (280 mgI/ml) and Conray 60 (iothalmate meglumine, 282 mgI/ml).
• A total of 51 selective injections were analyzed for pain, burning, and motion.

Main Results:

• Iopamidol resulted in significantly less pain and burning compared to Conray 60.
• Iopamidol administration did not cause any patient motion.
• These findings suggest superior tolerability of iopamidol.

Conclusions:

• Iopamidol is a well-tolerated contrast agent for cerebral arteriography.
• The reduced pain and lack of motion with iopamidol may enhance image quality and patient experience.
• Iopamidol represents a favorable alternative to Conray 60 in neurovascular imaging.